Potential roles of carnitine in patients with polycystic ovary syndrome: a systematic review

References

• Burks HR, Wild RA. Diagnostic criteria and epidemiology of PCOS. In: Lubna P, editor. Polycystic ovary syndrome. New York, NY: Springer; 2014. p. 3–10.
   Google Scholar
• Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
   PubMed Web of Science ®Google Scholar
• McCartney CR, Marshall JC. Clinical practice. Polycystic ovary syndrome. N Engl J Med. 2016;375:54–64.
   PubMed Web of Science ®Google Scholar
• Catteau-Jonard S, Dewailly D. Pathophysiology of polycystic ovary syndrome: the role of hyperandrogenism. In: Macut DP, M; Yildiz, B.O; Diamanti-Kandarakis, editor. Polycystic ovary syndrome. Vol. 40, Basel: Karger Publishers; 2013. p. 22–27.
   Google Scholar
• Balen A. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology. Best Pract Res Clin Obstet Gynaecol. 2004;18:685–706.
   PubMed Web of Science ®Google Scholar
• Rebouche CJ. In: Erdman Jr JW MI, Zeisel SH, editor. L‐Carnitine. Present knowledge in nutrition. 10th ed. USA: John Wiley & Sons; 2012. p. 391–404..
   Google Scholar
• Borum PR. Carnitine homeostasis in humans. In: Wall BT PC, editor. Carnitine metabolism and human nutrition. CRC Press; 2014. p. 3..
   Google Scholar
• Mynatt R, Noland R, Wicks S. Carnitine and insulin resistance. In: Benjamin T. Wall CP, editor. Carnitine metabolism and human nutrition. CRC Press; 2016. p. 114–143.
   Google Scholar
• Xu Y, Jiang W, Chen G, et al.L-carnitine treatment of insulin resistance: a systematic review and meta-analysis. Adv Clin Exp Med. 2017;26:333 –338.
   Google Scholar
• Berg SM, Beck-Nielsen H, Faergeman NJ, et al. Carnitine acetyltransferase: a new player in skeletal muscle insulin resistance? Biochem Biophys Rep. 2017;9:47–50.
   PubMedGoogle Scholar
• Schooneman MG, Vaz FM, Houten SM, et al. Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes. 2013;62:1–8.
   PubMed Web of Science ®Google Scholar
• Mynatt RL. Carnitine and type 2 diabetes. Diabetes Metab Res Rev. 2009;25:45–49.
   Google Scholar
• Chiu KM, Schmidt MJ, Havighurst TC, et al. Correlation of serum L-carnitine and dehydro-epiandrosterone sulphate levels with age and sex in healthy adults. Age Ageing. 1999;28:211–216.
   PubMed Web of Science ®Google Scholar
• Takiyama N, Matsumoto K. Age-and sex-related differences of serum carnitine in a Japanese population. J Am Col Nutr. 1998;17:71–74.
   PubMed Web of Science ®Google Scholar
• Messinis IE, Messini CI, Anifandis G, et al. Polycystic ovaries and obesity. Best Pract Res Clin Obstet Gynaecol. 2015;29:479–488.
   PubMed Web of Science ®Google Scholar
• Celik F, Kose M, Yilmazer M, et al. Plasma L-carnitine levels of obese and non-obese polycystic ovary syndrome patients. J Obstetr Gynaecol. 2017;37:476–479.
   PubMed Web of Science ®Google Scholar
• Fenkci SM, Fenkci V, Oztekin O, et al. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Human Reprod. 2008;23:1602–1606.
   PubMed Web of Science ®Google Scholar
• Jamilian H, Jamilian M, Samimi M, et al. Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Gynecol Endocrinol. 2017;33:442–447.
   PubMed Web of Science ®Google Scholar
• Samimi M, Jamilian M, Ebrahimi FA, et al. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double‐blind, placebo‐controlled trial. Clin Endocrinol. 2016;84:851–857.
   PubMed Web of Science ®Google Scholar
• Ismail AM, Hamed AH, Saso S, et al. Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial. Europ J Obstet Gynecol Reprod Biol. 2014;180:148–152.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Christakou CD. Insulin resistance in PCOS. In: Farid NR D-KE, editor. Diagnosis and management of polycystic ovary syndrome. Boston: Springer; 2009. p. 35–61..
   Google Scholar
• Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Rev. 2012;33:981–1030.
   PubMed Web of Science ®Google Scholar
• Virmani M, Krsmanovic L, Stojilkovic S, et al., editors. Stimulatory effects of L-acetyl carnitine on the pituitary-gonadal axis in female rats. Advances in Human Female Reproduction. Sereno Symposium Publication; 1991.
   Google Scholar
• Genazzani AD, Despini G, Czyzyk A, et al. Modulatory effects of L-carnitine plus L-acetyl-carnitine on neuroendocrine control of hypothalamic functions in functional hypothalamic amenorrhea (FHA). Gynecol Endocrinol. 2017;33:963–967.
   PubMed Web of Science ®Google Scholar
• Ringseis R, Keller J, Eder K. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency. Eur J Nutr 2012;51:1–18.
   PubMed Web of Science ®Google Scholar
• Vigerust NF, Bohov P, Bjørndal B, et al. Free carnitine and acylcarnitines in obese patients with polycystic ovary syndrome and effects of pioglitazone treatment. Fertil Steril 2012;98:1620–1626. e1.
   PubMed Web of Science ®Google Scholar
• Latifian l, Hamdiand K, Totakhneh R. Effect of addition of L-carnitine in polycystic ovary syndrome (pcos) patients with clomiphene citrate and gonodotropin resistant [original article]. Int J Curr Res Acad Rev. 2015;3:469–476.
   Google Scholar
• Ollila M-ME, Piltonen T, Puukka K, et al. Weight gain and dyslipidemia in early adulthood associate with polycystic ovary syndrome: prospective cohort study. J Clin Endocrinol Metabol. 2016;101:739–747.
   PubMed Web of Science ®Google Scholar
• Serban M-C, Sahebkar A, Mikhailidis DP, et al. Impact of L-carnitine on plasma lipoprotein (a) concentrations: a systematic review and meta-analysis of randomized controlled trials. Sci Rep. 2016;6:19188.
   PubMed Web of Science ®Google Scholar
• Wang X, Guo F, Pan Y, et al., editors. A meta-analysis of effect of L-carnitine on lipid levels in obese patients. Basic & clinical pharmacology & toxicology. Hoboken, NJ, USA: Wiley-Blackwell; 2016.
   Google Scholar
• Goetsch AL, Kimelman D, Woodruff TK. Polycystic ovary syndrome. In: Goetsch AL KD, Woodruff TK, editor. Fertility preservation and restoration for patients with complex medical conditions. Chicago: Springer; 2017. p. 231–248..
   Google Scholar
• Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine Rev. 2016;37:467–520.
   PubMed Web of Science ®Google Scholar
• Lin X, Wu R, Du J, et al. Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS). Clin Exp Obstet Gynecol. 2015;42:315–320.
   PubMed Web of Science ®Google Scholar
• Wicks S, Noland R, Mynatt R. Carnitine and insulin resistance. In: Benjamin T. Wall CP, editor. Carnitine metabolism and human nutrition. CRC Press 2014. p. 97.
   Google Scholar
• Pooyandjoo M, Nouhi M, Shab‐Bidar S, et al. The effect of (L‐) carnitine on weight loss in adults: a systematic review and meta‐analysis of randomized controlled trials. Obesity Rev. 2016;17:970–976.
   PubMed Web of Science ®Google Scholar
• Cha Y-S. Effects of L-carnitine on obesity, diabetes, and as an ergogenic aid. Asia Pac J Clin Nutr. 2008;17:306–308.
   PubMed Web of Science ®Google Scholar
• Center SA, Warner KL, Randolph JF, et al. Influence of dietary supplementation with (L)-carnitine on metabolic rate, fatty acid oxidation, body condition, and weight loss in overweight cats . Am J Vet Res. 2012;73:1002–1015.
   PubMed Web of Science ®Google Scholar
• Vidal-Casariego A, Burgos PR, Martinez-Faedo C, et al. Metabolic effects of L-carnitine on type 2 diabetes mellitus: systematic review and meta-analysis. Exp Clin Endocrinol Diabetes. 2013;121:234–238.
   PubMed Web of Science ®Google Scholar
• Bene J, Hadzsiev K, Melegh B. Role of carnitine and its derivatives in the development and management of type 2 diabetes. Nutr Diabetes. 2018;8:8.
   PubMed Web of Science ®Google Scholar
• Stephens FB, Constantin Teodosiu D, Greenhaff PL. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol (Lond). 2007;581:431–444.
   Google Scholar
• Bremer J. The role of carnitine in intracellular metabolism. J Clin Chem Clin Biochem. 1990;28:297–301.
   PubMedGoogle Scholar
• Lopaschuk GD, Altamimi TR. Role of carnitine in modulation of muscle energy metabolism and insulin resistance. In: Benjamin T. Wall CP, editor. Carnitine metabolism and human nutrition. CRC Press; 2016. p. 28–51..
   Google Scholar
• Bargiota A, Diamanti-Kandarakis E. The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol metab. 2012;3:27–47.
   PubMedGoogle Scholar
• DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173–194.
   PubMed Web of Science ®Google Scholar
• Gómez-Amores L, Mate A, Revilla E, et al. Antioxidant activity of propionyl-L-carnitine in liver and heart of spontaneously hypertensive rats. Life Sci. 2006;78:1945–1952.
   PubMed Web of Science ®Google Scholar
• Power R, Hulver M, Zhang J, et al. Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia. 2007;50:824–832.
   PubMed Web of Science ®Google Scholar
• Huang H, Song L, Zhang H, et al. Influence of L-carnitine supplementation on serum lipid profile in hemodialysis patients: a systematic review and meta-analysis. Kidney Blood Press Res. 2013;38:31–41.
   PubMed Web of Science ®Google Scholar
• Lysiak W, Lilly K, DiLisa F, et al. Quantitation of the effect of L-carnitine on the levels of acid-soluble short-chain acyl-CoA and CoASH in rat heart and liver mitochondria. J Biol Chem. 1988;263:1151–1156.
   PubMed Web of Science ®Google Scholar
• Bremer J. Carnitine-metabolism and functions. Physiol Rev. 1983;63:1420–1480.
   PubMed Web of Science ®Google Scholar
• Garlid KD. Physiology of mitochondria. In: Sperelakis N, editor. Cell physiology source book. 3rd ed. Ohio: Elsevier; 2001. p. 139–151.
   Google Scholar
• Shorakae S, Teede H, de Courten B, et al., editors. The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome. Seminars in reproductive medicine. New York: Thieme Medical Publishers; 2015.
   Google Scholar
• González F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77:300–305.
   PubMed Web of Science ®Google Scholar
• Glintborg D, Andersen M. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol. 2010;26:281–296.
   PubMed Web of Science ®Google Scholar
• González F, Rote NS, Minium J, et al. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:336–340.
   PubMed Web of Science ®Google Scholar
• González F, Rote NS, Minium J, et al. Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:1508–1512.
   PubMed Web of Science ®Google Scholar
• Abdelhadi O, Shepard M, Sia C, et al. Activation of nuclear factor κB in response to cream ingestion is related to ovarian androgen hypersecretion in polycystic ovary syndrome. Fertil Steril. 2013;100:S39.
   PubMed Web of Science ®Google Scholar
• Surai PF. Antioxidant action of carnitine: molecular mechanisms and practical applications. EC Vet Sci. 2015;2:66–84.
   Google Scholar
• Infante JP, Tschanz CL, Shaw N, et al. Straight-chain acyl-coa oxidase knockout mouse accumulates extremely long chain fatty acids from alpha-linolenic acid: evidence for runaway carousel-type enzyme kinetics in peroxisomal beta-oxidation diseases . Mol Genet Metab. 2002;75:108–119.
   PubMed Web of Science ®Google Scholar
• Abdelrazik H, Sharma R, Mahfouz R, et al. L-carnitine decreases DNA damage and improves the in vitro blastocyst development rate in mouse embryos. Fertil Steril. 2009;91:589–596.
   PubMed Web of Science ®Google Scholar
• Winter B, Fiskum G, Gallo L. Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock. Br J Cancer. 1995;72:1173.
   PubMed Web of Science ®Google Scholar
• Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod. 2001;16:1255–1260.
   PubMed Web of Science ®Google Scholar
• Kirchengast S, Huber J. Body composition characteristics and fat distribution patterns in young infertile women. Fertil Steril. 2004;81:539–544.
   PubMed Web of Science ®Google Scholar
• Yucel A, Noyan V, Sagsoz N. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome. Europ J Obstet Gynecol Reprod Biol. 2006;126:81–86.
   PubMed Web of Science ®Google Scholar
• Spritzer PM, Lecke SB, Satler F, et al. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149:R219–27.
   PubMed Web of Science ®Google Scholar
• Delitala AP, Capobianco G, Delitala G, et al. Polycystic ovary syndrome, adipose tissue and metabolic syndrome. Arch Gynecol Obstet. 2017;296:405–419.
   PubMed Web of Science ®Google Scholar
• Freemark M, Collins S. Brown adipose tissue and body weight regulation. In: Freemark MS, editor. Pediatric obesity. USA: Humana Press, Cham; 2018. p. 117–132..
   Google Scholar
• Chondronikola M, Volpi E, Børsheim E, et al. Brown adipose tissue activation is linked to distinct systemic effects on lipid metabolism in humans. Cell Metab. 2016;23:1200–1206.
   PubMed Web of Science ®Google Scholar
• Villarroya F, Cereijo R, Villarroya J, et al. Brown adipose tissue as a secretory organ. Nat Rev Endocrinol. 2017;13:26.
   Google Scholar
• Chondronikola M, Volpi E, Børsheim E, et al. Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes. 2014;63:4089–4099.
   PubMed Web of Science ®Google Scholar
• Fu X, Xu W, Qiu S, et al. Research progress on the relationship of brown adipose tissue with polycystic ovary syndrome. J Zhejiang Univ Med Sci. 2017;46:315–320.
   Google Scholar
• Shorakae S, Jona E, Lambert G, et al.Brown adipose tissue thermogenesis in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2017;49:GP135..
   Google Scholar
• Ozaki K, Sano T, Tsuji N, et al. Carnitine is necessary to maintain the phenotype and function of brown adipose tissue. Lab Invest 2011;91:704.
   PubMed Web of Science ®Google Scholar